Showing results (1341-1350 of 8,960) with videos related to
Sort By:
Pageof 896
Journal of Hepatology|November 28, 2012
Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failureGraham R Foster, Stefan Zeuzem, Pietro Andreone, et al.Journal of Hepatology|November 28, 2012
miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosisChristoph Roderburg, Mark Luedde, David Vargas Cardenas, et al.Journal of Hepatology|November 28, 2012
Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trialMaribel Rodriguez-Torres, Eric Lawitz, Kris V Kowdley, et al.Journal of Hepatology|May 23, 2012
Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large populationThierry Poynard, Mona Munteanu, Olivier Deckmyn, et al.Journal of Hepatology|May 23, 2012
OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinomaWen Yang, Chao Wang, Yan Lin, et al.Journal of Hepatology|May 23, 2012
Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1Eiichi Ogawa, Norihiro Furusyo, Masayuki Murata, et al.Journal of Hepatology|May 23, 2012
Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirinYvon Calmus, Christophe Duvoux, Georges Pageaux, et al.Journal of Hepatology|May 23, 2012
Cholestasis-induced pruritus treated with ultraviolet B phototherapy: an observational case series studySofie Decock, Rik Roelandts, Werner Van Steenbergen, et al.Journal of Hepatology|November 27, 2012
Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevirYoshiyasu Karino, Joji Toyota, Kenji Ikeda, et al.Journal of Hepatology|December 4, 2013
HOPE for human liver grafts obtained from donors after cardiac deathPhilipp Dutkowski, Andrea Schlegel, Michelle de Oliveira, et al.Pageof 896